Marta Sorokina Alexdottir (Marta S Alexdottir)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tissue Engineering

Disease Activity

Extracellular Matrix

Rheumatoid Arthritis Patients

Top Venues

Journal of clinical medicine

Alimentary pharmacology & therapeutics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Pehrsson, Viktor Domislović, Marta Sorokina Alexdottir, Marko Brinar, Morten Asser Karsdal, Ana Barisic, Zeljko Krznaric, Joachim Høg Mortensen
Blood-Based Biomarkers Reflecting Protease 3 and MMP-12 Catalyzed Elastin Degradation as Potential Noninvasive Surrogate Markers of Endoscopic and Clinical Disease in Inflammatory Bowel Disease. Journal of clinical medicine 13 (1) (2023)
Martin Pehrsson, Viktor Domislović, Marta Sorokina Alexdottir, Marko Brinar, Morten Asser Karsdal, Ana Barisic, Zeljko Krznaric, Joachim Høg Mortensen
Blood-Based Biomarkers Reflecting Protease 3 and MMP-12 Catalyzed Elastin Degradation as Potential Noninvasive Surrogate Markers of Endoscopic and Clinical Disease in Inflammatory Bowel Disease. Journal of clinical medicine 13 (1) (2023)
Arno R Bourgonje, Marta Sorokina Alexdottir, Antonius Timotheus Otten, Roberta Loveikyte, Anne Christine Bay-Jensen, Martin Pehrsson, Hendrik M van Dullemen, Marijn C Visschedijk, Eleonora A M Festen, Rinse K Weersma, Morten Asser Karsdal, Klaas Nico Faber, Joachim Høg Mortensen, Gerard Dijkstra
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease. Alimentary pharmacology & therapeutics 56 (4) (2022)
Marta Sorokina Alexdottir, Arno R Bourgonje, Morten A Karsdal, Martin Pehrsson, Roberta Loveikyte, Hendrik M van Dullemen, Marijn C Visschedijk, Eleonora A M Festen, Rinse K Weersma, Klaas Nico Faber, Gerard Dijkstra, Joachim H Mortensen
Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease. International journal of molecular sciences 23 (15) (2022)